Dr. Reddy’s Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US.
Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which according to IMS Health data had total sales of $5.3m in the US for the twelve months ending November 2012.
The company makes Desloratadine ODT of 2.5mg and 5mg strengths available in unit dose packages of 30.
Clarinex Reditabs is indicated to fight allergy with the same strength of Clarinex but with the additional convenience of a rapid disintegration without water.
The prescription nonsedating, antihistamine was approved for the treatment of indoor and outdoor allergies and hives of unknown cause.